top of page
#WCIRDC24
CME Conference on December 12-14, 2024
Hilton Universal Hotel Los Angeles
555 Universal Hollywood Dr, Universal City, CA 91608
Virtual Poster Hall
21st WCIRDC
Accepted Abstracts 2023
Abstracts will be published in the Metabolism Journal
Editor-in-Chief: Christos S. Mantzoros, MD, DSc, PhD h.c. mult.
Congratulations to the Top 6 Abstracts.
#0023, #0035, #0044, #0071, #0077, #0088
the Oral Abstract Booklet.
#0001
Pancreatic Shear Wave Elastography in Children and Adolescents with Type 1 Diabetes; Relation to Pancreatic Residue
Author/s:
Nouran Yousef Salah1, Sherihane Said Madkour2, Khaled Sayed Soliman2
Organizations/Affiliations:
Ain Shams University
Main Contact Person's Name:
Nouran Salah
Main Contact Person's E-Mail
nouranyousef@med.asu.edu.eg
#0003
The Function and Roles of ADAMTS-7 in Experimental Diabetic Cardiomyopathy
Author/s:
Nihat Yumusak*, DVM, PhD,*, Associate Professor of the Department of Pathology, Veterinary Medical Faculty of Harran University, Akin Yigin, DVM, PhD,*, Associate Professor of the Department of Genetics, Veterinary Medical Faculty of Harran University
Organizations/Affiliations:
Harran University, 63100, Sanliurfa, Turkey
Main Contact Person's Name:
Nihat Yumusak
Main Contact Person's E-Mail:
nihatyumusak@harran.edu.tr
#0004
Prevalence of kidney and Hepatic Dysfunction, and Outcomes in Hospitalized Patients With COVID-19 Infection in SBA region (west of Algeria)
Author/s:
Demmouche Abbassia*, Abdallah Touati Djihène, Bouazza Sofiane ; Belmous Asmaa ; Bekhadda Hadjer : Itatahine Amina ; Mai Hicham
Organizations/Affiliations:
Biotoxicology laboratory, Department of Biology, Faculty of Natural Sciences and life-Djillali Liabes University of Sidi Bel Abbes, Algeria
Main Contact Person's Name:
DEMMOUCHE Abbassia
Main Contact Person's E-Mail:
demmoucheabbassia@yahoo.fr
#0005
Semaglutide and lanifibranor Differentially Alter NASH and Liver Fibrosis in Diet-Induced Obese Hamsters With or Without Free Access to Alcohol
Author/s:
Francois Briand, Ph.D, Estelle Grasset, Ph.D, Natalia Breyner, Ph.D, Thierry Sulpice, Ph.D
Organizations/Affiliations:
PHYSIOGENEX
Main Contact Person's Name:
FRANCOIS BRIAND
Main Contact Person's E-Mail
f.briand@physiogenex.com
#0006
Inverse Relationship Between Creatinine-to-Body Weight (Cre/BW) Ratio and Incident Diabetes in a Multiethnic Cohort.
Author/s:
Noraidatulakma Abdullah,PhD, Senior Lecturer, Goh Ying Xian, MSc, Research Officer, Aisyatul Najihah Khuzaimi, Bsc, Research Officer, Azwa Shawani Kamalul Arifin, BSc, Science Officer, Nurul Ain Mhd Yusuf, MSc, Science Officer, Nazihah Abd Jalal, BSc, Science Officer, Norliza Ismail, BSc, Science Officer, Nurul Faeizah Husin, MSc, IT Officer, Rahman Jamal, PhD, MD, Professor.
Organizations/Affiliations:
Universiti Kebangsaan Malaysia Medical Molecular Biology Institute (UMBI)
Main Contact Person's Name:
Noraidatulakma Abdullah
Main Contact Person's E-Mail:
noraidatulakma.abdullah@ppukm.ukm.edu.my
#0007
Microbial Metabolite UDP-Galactose Restores Islet β-cell Function in Mice via the Gut–Islet Axis
Author/s:
Feng Zhang, PhD
Organizations/Affiliations:
Affiliated Hospital of Jiangnan University
Main Contact Person's Name
Feng Zhang
Main Contact Person's E-Mail:
fengzhang@jiangnan.edu.cn
#0008
Humanistic and Economic Burden of Patients With Cardiorenal Metabolic (CRM) Conditions: A Systematic Literature Review
Author(S): 1. Keith C. Ferdinand, MD; 2. Keith C. Norris, MD PhD; 3. Helena W. Rodbard, MD; 4. Jennifer M. Trujillo, PharmD
Organization/Affiliation:
1. Tulane University School of Medicine, Cardiology Section, New Orleans, LA; 2. Department of Medicine, Division of General Internal Medicine and Health Services Research, University of California, Los Angeles, Los Angeles, CA; 3. Endocrine and Metabolic Consultants, Rockville, MD; 4. Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Aurora, CO
Main Contact Person's Name:
Paul Lidbury
Main Contact Person's E-Mail:
paul.lidbury@envisionpharma.com
#0009
Healthcare Professionals’ Perceptions of Obesity & Agonists of the Glucagon,
GLP-1 & GIP Receptors
Author(S): 1. W. Timothy Garvey, MD; 2. Cathy D. Mahle, PhD; 3. Robert F. Kushner, MD
Organization/Affiliation
1. University of Alabama at Birmingham, Birmingham, AL, USA; 2. Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, CT, USA; 3. Northwestern University Feinberg School of Medicine, Chicago, IL, USA
Main Contact Person's Name:
Paul Lidbury
Main Contact Person's E-Mail:
paul.lidbury@envisionpharma.com
#0010
Biochemical Investigation Of Genetic Polymorphism Of Mthfr (C677t) Rs 1801133 With Myocardial Infarction
Author/s:
Muhammad Sajid Hamid Akash1, Momina Shahid2, Kanwal Rehman2, Tauqeer Hussain Mallhi4, Yusra Habib Khan4
Organizations/Affiliations:
1Department of Pharmaceutical Chemistry, Government College University, Faisalabad, Pakistan. 2Department of Pharmacy, The University of Faisalabad, Faisalabad, Pakistan. 3Department of Pharmacy, The Women University, Multan, Pakistan. 4Department of Clinical Pharmacy, College of Pharmacy, Jouf University, Sakaka 72388, Saudi Arabia
Main Contact Person's Name:
Muhammad Sajid Hamid Akash
Main Contact Person's E-Mail:
sajidakash@gcuf.edu.pk
#0011
Biochemical Association Of Genetic Mutation Of Klf14 Rs4731702 With Risk Factors Of Diabetes Mellitus
Author/s:
Muhammad Sajid Hamid Akash1, Sumbal Rasheed1, Kanwal Rehman2, Tauqeer Hussain Mallhi3, Yusra Habib Khan3
Organizations/Affiliations:
1Department of Pharmaceutical Chemistry, Government College University, Faisalabad, Pakistan. 2Department of Pharmacy, The Women University, Multan, Pakistan. 3Department of Clinical Pharmacy, College of Pharmacy, Jouf University, Sakaka 72388, Saudi Arabia
Main Contact Person's Name:
Muhammad Sajid Hamid Akash
Main Contact Person's E-Mail:
sajidakash@gcuf.edu.pk
#0013
Levels of Biomarkers of Fibrosis in Patients with Diabetes Mellitus Type 2
Author(S): K.Tchaava, N.Gegeshidze, N.Ninashvili, T.Giorgadze, N.Kilasonia
Organization/Affiliation:
Tbilisi State Medical University, Georgian Technical University, Georgia
Organization/Affiliation
Tbilisi State Medical University, Georgian Technical University, Georgia
Main Contact Person's Name:
Khatuna Tchaava
Main Contact Person's E-Mail:
khatuna_chaava@mail.ru
#0015
Risk of Obesity, Diabetes, Insulin Resistance, and Dyslipidemia Among Irritable Bowel Syndrome Patients.
Author(S): Yomna E. Dean 1, Jose Jonathan Loayza Pintado 2, Lucy L. Nale 3, Samah S. Rouzan 1, Ahmed Abbas 4, Mohamed Doma 1, Abdulla M. Aboushaira 1, Farah Alkasajy 5, Ahmed A. Ghanem 6, Vinayak Mahesh Patil 7, Yana Gordeyeva 8, Karam R. Motawea 1, Masako Lien Le 8, Adham Galal 1, Laura Cicani 9, Raneem Mohamed Atta 1, Sameh Samir Elawady 10, Lamya Alzabidi 11, Ahmed Soliman 12, Tamer Mady 13, Hani Aiash 14
Organization/Affiliation:
1: Alexandria University 2: Universidad de San Martín de Porres 3: Windsor University School of Medicine 4: Zagazig university 5: Hashemite University 6: Mansoura University 7: Karnataka Institute of Medical Sciences 8: Poznan University of Medical Sciences 9: International University of Health Sciences 10: Neuro-endovascular Surgery Department, Medical University of South Carolina (MUSC) 11: Faculty of Medicine and Health Sciences, Sanaa University 12: Ain Shams University 13: International American University College of Medicine 14: SUNY Upstate Medical University
Main Contact Person's Name:
Yomna E. Dean
Main Contact Person's E-Mail:
Yomnadean@gmail.com
#0017
Influence of Lipid Profile on the Risk of Carcinoma Breast in North Indian Women
Author/s:
*Dr Snehal Sawant, Senior Resident ,Department of Biochemistry Dr Anita Rani ,Director -Professor Department of Biochemistry Dr S. V. Arya Consultant, Professor and Head of Unit , Department of Surgery , ** Dr Prabhpreet Bhogal, GDMO Emergency Medicine
Organizations/Affiliations:
*Vardhman Mahavir Medical college & Safdarjung Hospital New Delhi, **Delhi Cantonement General Hospital New delhi
Main Contact Person's Name:
Dr. Snehal Sawant
Main Contact Person's E-Mail:
dr.snehal007@gmail.com
#0018
Low Muscle Strength as a Risk Factor for Non-Alcoholic Fatty Liver Disease in Different Metabolic Subgroups
Author(S):
Hye-Sun Rho, Whan-Seok Choi
Organization/Affiliation:
Department of Family Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
Main Contact Person's Name:
Hye-Sun Rho
Main Contact Person's E-Mail:
hyesunnote@gmail.com
#0019
Association of Serum Vitamin D Level and Type 2 Diabetes with Nonalcoholic Fatty Liver Disease
Author/s:
Maosheng Lee1,2, Siping Peng1,2, Xiaohui Xiao2, Zengying Li1,2, Hengxia Zhao1,2, Huilin Li1,2*
Organizations/Affiliations:
The Fourth Clinical Medical College, Guangzhou University of Chinese Medicine
Main Contact Person's Name:
Maosheng Lee
Main Contact Person's E-Mail:
realsmile365@163.com
#0020
The Relationship Between Vitamin D level and Sarcopenia : Insights from a Korean Population Study
Author/s:
Shinyoung Roh, M.D., Kyung-Soo Kim, M.D.
Organizations/Affiliations:
Department of Family Medicine, Seoul St. Mary's Hospital, The Catholic University Medical Center of Korea
Main Contact Person's Name:
Shinyoung Roh, M.D.
Main Contact Person's E-Mail:
1brilliant@naver.com
#0022
Maternal Dehydration Contributes to the Development of Salt Sensitivity of Blood Pressure (SSBP) in Offspring, with its Influence Likely Tied to an Elevation in Vasopressin Secretion.
Author(S):
Kim Y-B, PhD, Jung WW, PhD, Jin X, MD, PhD., Kang HK, MS, Kim YI, PhD
Organization/Affiliation:
Department of Physiology and Neuroscience Research Institute, Korea University College of Medicine, Seoul 02841, Republic of Korea
Main Contact Person's Name:
Yang In Kim
Main Contact Person's E-Mail:
yikim@korea.ac.kr
#0023
A Phase II, randomized, double-blind, placebo-controlled, dose-finding study of survodutide (BI 456906) in people living with overweight/obesity
Author(S):
1. M Carel W Le Roux, BChB, MSC, FRCP, FRCPath, PhD; 2. Oren Steen, MD, FRCPC; 3. Kathryn J Lucas, MD; 4. Elena Startseva, MD, MBA; 5. Luiza Borowska MD; 6. Anna Unseld, Dipl Stat
Organization/Affiliation:
1. School of Medicine, St. Vincent's University Hospital and University College Dublin, Dublin, Ireland; 2. LMC Diabetes & Endocrinology, Toronto, Ontario, Canada; 3. Diabetes & Endocrinology Consultants PC, Morehead City, NC, USA; 4. Boehringer Ingelheim International GmbH, Ingelheim, Germany; 5. Boehringer Ingelheim International GmbH, Ingelheim, Germany; 6. Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach/Riss, Germany
Main Contact Person's Name:
Paul Lidbury
Main Contact Person's E-Mail:
paul.lidbury@envisionpharma.com
#0025
Improving Health Care Staff Knowledge on Women’s Heart Health Through a Multi-Layered Approach
Author/s:
Nazli Parast; Thais Coutinho; Amelie Paquin; Bonnie Quinlan; Amy Charlebois; Kara Murfitt; Heather Tulloch; Stephanie LEBLANC; Tammy Lafreniere; Helena Van Ryn; Deborah Younger-Lewis; Sandra Wong; Bonnie Bowes; Lindsay MacArthur
Organizations/Affiliations:
University of Ottawa Heart Institute
Main Contact Person's Name:
Nazli Parast
Main Contact Person's E-Mail:
naparast@ottawaheart.ca
#0026
Evaluating Cross Talk Between Insulin Resistance, Inflammation And Fibrosis Along With Exploring Therapeutic Potential Of Beta Vulgaris In Experimentally Induced Diabetic Cardiomyopathy In Rat Model
Author/s:
Laaraib Nawaz (PhD scholar), Ayesha Saddiqa (MPhil scholar), Haseeb Anwar (Associate Professor)
Organizations/Affiliations:
Health Biology Laboratory, Department of Physiology, Faculty of Life Sciences,Government College University Faisalabad 38000 Punjab Pakistan
Main Contact Person's Name:
Dr. Haseeb Anwar
Main Contact Person's E-Mail:
drhaseebanwar@gcuf.edu.pk
#0033
NP 0033 Profiling Of Putative Mirnas (8-Mer) Against The T2DM And MI Associated Genes
Author/s:
Khadam Hussain, Ayesha Ishtiaq, Iram Murtaza*
Organizations/Affiliations:
, Signal Transduction Laboratory, Department of Biochemistry, Quaid i Azam University, Islamabad, 45320, Pakistan
Main Contact Person's Name:
Iram Murtaza
Main Contact Person's E-Mail:
irambch@qau.edu.pk
#0034
The Association Of Insulin Resistance And Mild Cognitive Impairment In Elderly Patients With Alzheimer's Disease
Author/s:
Yethindra Vityala1; Tugolbai Tagaev2; Sai Kiran Ramanujam3; Immi Harshitha Kalapala4; Afreen Begum Kaggallu5; Sameena Sultana4; Gowtham Devara4; Altynai Zhumabekova2; Krishna Priya Kanteti3; Ujwala Damineni6
Organizations/Affiliations:
1AJ Institute of Medical Sciences and Research Centre Mangalore, Karnataka, India; 2I.K. Akhunbaev Kyrgyz State Medical Academy, Bishkek, Kyrgyzstan; 3Gandhi Medical College and Hospital, Secunderabad, Telangana, India; 4Siddhartha Medical College, Vijayawada, Andhra Pradesh, India; 5Vijayanagar Institute of Medical Sciences, Ballari, Karnataka, India, 6Maheshwara Medical College and Hospital, Hyderabad, Telangana, India
Main Contact Person's Name:
Yethindra Vityala
Main Contact Person's E-Mail:
yethindravityala10@gmail.com
#0035
Reduced Lipotoxicity Following Triple Therapy for 3 Years in New Onset T2DM
Author/s:
Olga Lavynenko, MD, PhD, Muhammad Abdul-Ghani, MD, PhD, and Ralph A. DeFronzo, MD
Organizations/Affiliations:
Division of Endocrinology, Diabetes, & Metabolism, Beth Israel Deaconess Medical Center, Boston, MA and Diabetes Division UT Health & Texas Diabetes Institute, San Antonio, Tx
Main Contact Person's Name:
Olga Lavrynenko
Main Contact Person's E-Mail:
olgalavrynenko@gmail.com
#0036
Exploring The Role Of Insulin Resistance In Neurodegenerative Disorders: Insights From Clinical And Neuroimaging Analysis
Author/s:
Komal Jabeen1,2, Kanwal Rehman3, Muhammad Sajid Hamid Akash4
Organizations/Affiliations:
1Institute of Physiology and Pharmacology, University of Agriculture, Faisalabad, Pakistan. 2Department of Pharmacy, Niazi Medical and Dental College, Sargodha 40100, Pakistan 3Department of Pharmacy, The Women University, Multan, Pakistan. 4Department of Pharmaceutical Chemistry, Government College University, Faisalabad, Pakistan.
Main Contact Person's Name:
Muhammad Sajid Hamid Akash
Main Contact Person's E-Mail:
sajidakash@gcuf.edu.pk
#0037
Comparison of Glucose and Insulin Profile Between Normal and Prediabetic Subjects
Author/s:
Ava S Kumar*, Joseph W Babiarz
Organizations/Affiliations:
Aspirus Wausau Hospital, Wausau, WI, *DC Everest High School, Weston, WI
Main Contact Person's Name:
Ava S Kumar
Main Contact Person's E-Mail:
avakumar@icloud.com
#0040
Association of eating-out rate with metabolic syndrome in Korean adults: from the Korean National Health and Nutrition Examination Survey 2016
Author/s:
Jaedong LEE, M.D, Fellow
Organizations/Affiliations:
Department of Family Medicine, Eunpyeong ST. Mary's Hospital, Seoul, Korea
Main Contact Person's Name:
Jaedong LEE
Main Contact Person's E-Mail:
drleejd@gmail.com
#0041
Relationship Between Interleukin-6 -174 G/C Gene With IL-6 Level And Insulin Resistance In Adult Polycystic Ovary Syndrome Women
Author/s:
Abhishek Gupta, MSc, PGDBI, PhD and Vani Gupta, MBBS, MD, DNB, MNAMS
Organizations/Affiliations:
Department of Physiology, King George's Medical University, Lucknow-226003, UP, India
Main Contact Person's Name:
Dr. Abhishek Gupta
Main Contact Person's E-Mail:
abhikgmu@gmail.com
#0044
Carbohydrate Restriction-Induced Elevations In LDL-Cholesterol And Atherosclerosis: The KETO Trial
Author/s:
Matthew Budoff1, Venkat S. Manubolu1, April Kinninger1, Nicholas G. Norwitz2, David Feldman3, Thomas R. Wood4, Ricardo Cury5, Theodore Feldman5, Jonathan Fialkow5, Khurram Nasir6 1 Lundquist Institute at Harbor-UCLA Medical Center, Torrance, CA, United States 2 Harvard Medical School Boston, MA, United States 3 Citizen Science Foundation, Las Vegas, Nevada 4 Department of Pediatrics, University of Washington School of Medicine, Seattle, WA 98195, USA 5 Miami Cardiac and Vascular Institute, Baptist Health South Florida, Miami, FL, United States 6 Division of Cardiovascular Prevention and Wellness, Department of Cardiology, Houston Methodist DeBakey Heart & Vascular Center, Houston, TX, United States
Organizations/Affiliations:
Lundquist Institute at Harbor UCLA
Main Contact Person's Name:
Matthew Budoff
Main Contact Person's E-Mail:
mbudoff@lundquist.org
#0045
Associations Of Single Nucleotide Variants Of The FTO Gene With Metabolic Disorders In Children With Obesity
Author/s:
Aleksandr Abaturov, Anna Nikulina, Dmytro Nikulin
Organizations/Affiliations:
Dnipro State Medical University
Main Contact Person's Name:
Dmytro Nikulin
Main Contact Person's E-Mail:
dn0327481@gmail.com
#0046
Defining Cardio-renal-metabolic (CRM) Syndrome: A Targeted Literature Review
Author/s:
Brendan Clark, PharmD, MS (a), Mary Mulrooney, PharmD, MBA (b), Benjamin Miao, PharmD (a), Dheeraj Kataria, MPharma (b), Aishwarya Kulkarni, MS (b), Jeffrey R. Skaar, PhD (b)
Organizations/Affiliations:
(a) Boehringer Ingelheim Pharmaceuticals, Inc. (b) Trinity Life Sciences
Main Contact Person's Name
Brendan Clark
Main Contact Person's E-Mail:
brendan.clark@boehringer-ingelheim.com
#0047
Effect of empagliflozin on all-cause hospitalization in EMPA-KIDNEY
Author/s:
Anastasia Uster MD,1 Nihar Desai MD,2 Sankar D Navaneethan MD,3 Egon Pfarr MSc,1 Anna Rita Mazo MD1
Organizations/Affiliations:
1) Boehringer Ingelheim International GmbH, Ingelheim-am-Rhein, Germany 2) Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, CT, USA 3) Selzman Institute for Kidney Health, Section of Nephrology, Department of Medicine, Baylor College of Medicine, Houston, TX, USA.
Main Contact Person's Name:
Anastasia Uster
Main Contact Person's E-Mail:
anastasia.uster@boehringer-ingelheim.com
#0048
Sodium-dependent glucose transporter 2 inhibitor alleviates renal lipid deposition and improves renal oxygenation levels in newly diagnosed type 2 diabetes mellitus patients: a randomized controlled trial
Author(S):
Yunqi Wu, M.M., Li Zhang, M.B., Haizhen Sun, M.D., Guangyang Ma, M.D., Ph.D, Shan Lu, M.D., Saijun Zhou, M.D., Pei Yu, M.D.
Organization/Affiliation:
1.NHC Key Laboratory of Hormones and Development, Chu Hsien-I Memorial Hospital and Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin 300134, China 2.Tianjin Key Laboratory of Metabolic Diseases, Tianjin Medical University,Tianjin 300134, China
Main Contact Person's Name:
Yunqi Wu
Main Contact Person's E-Mail:
wyq67206@163.com
#0049
Visceral, Subcutaneous Fat And Bone Mineral Density Distribution In People With Cardiometabolic Risk Factors.
Author/s:
Adriana Janet Segura Saldaña1, RD; Diego Emiliano Chávez Fernández1, RD; Baldomero Morales Campos1, RD, MSc; Eliud Salvador Aguilar Barrera1,2, RD, MSc.
Organizations/Affiliations:
1Posgraduate Department, CICS-UMA, Instituto Politécnico Nacional. Mexico City, Mexico. 2Asociacion Mexicana para el Estudio de la Diabetes y sus Complicaciones, Mexico City, Mexico.
Main Contact Person's Name:
Eliud Salvador Aguilar Barrera
Main Contact Person's E-Mail:
aguilarbarrerae@gmail.com
#0050
The Role Of Vortex Flow Analysis By Contrast Echocardiography To Predict Clinical Outcome In Heart Failure With Reduced Ejection Fraction
Author/s:
In-Cheol Kim1, Se-In Park1*, Hye-Su Yun1, Gianni Pedrizzetti2, Geu-Ru Hong3
Organizations/Affiliations:
Keimyung University Dongsan Hospital, Division of Cardiology, Department of Internal Medicine, Cardiovascular Center, Daegu, Korea (Republic of)
Main Contact Person's Name:
In-Cheol Kim
Main Contact Person's E-Mail:
aupfe80@gmail.com
#0051
Elucidating The Diagnostic Potential Of Mirna In Coronary Artery Disease By Identifying Transcription Level Variations In Patients
Author/s:
Wishma Seher, Ayesha Ishtiaq, Iram Murtaza
Organizations/Affiliations:
Signal Transduction Laboratory, Quaid-i-Azam University, Islamabad, Pakistan
Main Contact Person's Name:
Ayesha Ishtiaq
Main Contact Person's E-Mail:
ayesha@bs.qau.edu.pk
#0052
C3ar1 On Beta Cells Preserves Beta Cell Function And Glucose Homeostasis In Diabetic Mice By Decreasing Metabolic Stress And Dedifferentiation
Author/s:
Renan Lima PhD, Ankit Gilani PhD, Lisa Stoll PhD, Eric Cortada PhD, Edwin Homan MD, PhD, Kou Ang Li, Deanndria Singleton, Tint Tha Ra Wun, James C. Lo MD, PhD
Organizations/Affiliations:
Weill Center for Metabolic Health, Cardiovascular Research Institute, Division of Cardiology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.
Main Contact Person's Name:
Renan Pereira de Lima
Main Contact Person's E-Mail:
rpl4002@med.cornell.edu
#0053
Relationship Between Obesity Indices measured with Body Composition Analyzer and Carotid Artery Plaques in Korean Middle-Aged Men
Author/s:
Salie Lee, MD, Bassam Yaghmour, MD, Soshin Kye, MD
Organizations/Affiliations:
Salie Lee, MD, Research Scholar, Division of Pulmonary and Critical Care, UC Irvine Bassam Yaghmour, MD, Associate Professor, Division of Pulmonary and Critical Care, UC Irvine Soshin Kye*, MD, Head of the Department of Family Medicine, National Police Hospital, Republic of Korea
Main Contact Person's Name
Salie Lee
Main Contact Person's E-Mail:
saliel@hs.uci.edu
#0054
Contribution Of SNV GLP1R In Diseasome Of Metabolically Unhealthy Obesity
Author/s:
Aleksandr Abaturov, Anna Nikulina, Dmytro Nikulin, Anastasiia Holikova, Daryna Dikhtyarenko
Organizations/Affiliations:
Dnipro State Medical University
Main Contact Person's Name:
Dmytro Nikulin
Main Contact Person's E-Mail:
dn0327481@gmail.com
#0055
Effect Of Diet On Insulin Resistance In Adults At Risk Of Developing Type 2 Diabetes Mellitus
Author/s:
Yethindra Vityala1; Rithwik Goud Burri2; Krishna Chaitanya Meduri2; Sai Praneeth Duvvuri2; Sriharsha Lankala2; Annie Monica Ch2; Raghu Ram Shanmukh Nemani3; Tejaswi Vadde4; Sai Prasad Karuturi4; Harish Kumar Jella4
Organizations/Affiliations:
1AJ Institute of Medical Sciences and Research Centre Mangalore, Karnataka, India; 2Maheshwara Medical College and Hospital, Hyderabad, Telangana, India; 3GSL Medical College and General Hospital, Rajahmundry, Andhra Pradesh, India; 4SVS Medical College, Mahbubnagar, Telangana, India
Main Contact Person's Name:
Yethindra Vityala
Main Contact Person's E-Mail:
yethindravityala10@gmail.com
#0057
0057 Effect of Finerenone on the Incidence of Hypokalemia in Patients With Type 2 Diabetes and Chronic Kidney Disease: A FIDELITY Analysis
Author/s:
Bertram Pitt, MD,1; Rajiv Agarwal, MD,2; Stefan D. Anker, MD,3; George L. Bakris, MD,4; Peter Rossing, MD,5,6; Luis Ruilope, MD,7-9; Charles A. Herzog, MD,10; Barry H. Greenberg, MD,11; Robert Pecoits-Filho, MD,12,13; Faiez Zannad, MD,14; Marc Lambelet, Dipl Math,15; Robert Lawatscheck, MD,16; Andrea Scalise, MD,17; Gerasimos Filippatos, MD,18; Asia Quan, PharmD,19; on behalf of the FIDELIO-DKD and FIGARO-DKD Investigators
Organizations/Affiliations:
1. Department of Medicine, University of Michigan School of Medicine Ann Arbor, MI, USA; 2. Indiana University School of Medicine and Richard L. Roudebush VA Medical Center, Indianapolis, IN, USA; 3. Department of Cardiology (CVK), and Berlin Institute of Health Center for Regenerative Therapies, German Centre for Cardiovascular Research Partner Site Berlin, Charité–Universitätsmedizin, Berlin, Germany; 4. Department of Medicine, University of Chicago Medicine, Chicago, IL, USA; 5. Steno Diabetes Center Copenhagen, Herlev, Denmark; 6. Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark; 7. Cardiorenal Translational Laboratory and Hypertension Unit, Institute of Research imas12, Madrid, Spain; 8. CIBERCV, Hospital Universitario 12 de Octubre, Madrid, Spain; 9. Faculty of Sport Sciences, European University of Madrid, Madrid, Spain; 10. Cardiology Division, Department of Internal Medicine, Hennepin Healthcare/University of Minnesota, Minneapolis, MN, USA; 11. University of California San Diego, La Jolla, CA, USA; 12. Arbor Research Collaborative for Health, Ann Arbor, MI, USA; 13. School of Medicine, Pontifícia Universidade Católica do Paraná, Curitiba, Brazil; 14. Henri Poincaré University, Nancy, France; 15. Chrestos Concept GmbH & Co. KG, Essen, Germany; 16. Cardiology and Nephrology Clinical Development, Bayer AG, Berlin, Germany; 17. Pharmaceutical Development, Bayer Hispania S.L., Barcelona, Spain; 18. National and Kapodistrian University of Athens, School of Medicine, Department of Cardiology, Attikon University Hospital, Athens, Greece; 19. Bayer US LLC, Whippany, NJ, USA
Main Contact Person's Name:
Asia Quan
Main Contact Person's E-Mail:
asia.quan@bayer.com
#0058
Effect of Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Baseline Anemia Status: A FIDELITY Analysis
Author/s:
Ajay Singh, MBBS,1; Stefan D. Anker, MD,2,3; Gerasimos Filippatos, MD,4; Bertram Pitt, MD,5; Peter Rossing, MD,6,7; Luis M. Ruilope, MD,8-10; Alfredo E. Farjat, PhD,11; Glen James, PhD,12; Youssef M.K. Farag, MD,PhD,13; Luke Roberts, MBBS PhD,14; George L. Bakris, MD,15; Tram Knecht, PharmD,13; on behalf of the FIDELIO-DKD and FIGARO-DKD Investigators
Organizations/Affiliations:
1. Renal Division, Harvard Medical School, Harvard University, Boston, MA, USA; 2. Department of Cardiology (CVK), and Berlin Institute of Health Center for Regenerative Therapies, German Centre for Cardiovascular Research Partner Site Berlin, Charité Universitätsmedizin, Berlin, Germany;3. Institute of Heart Diseases, Wrocław Medical University, Wrocław, Poland; 4. National and Kapodistrian University of Athens, School of Medicine, Department of Cardiology, Attikon University Hospital, Athens, Greece; 5. Department of Medicine, University of Michigan School of Medicine, Ann Arbor, MI, USA; 6. Steno Diabetes Center Copenhagen, Herlev, Denmark; 7. Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark; 8. Cardiorenal Translational Laboratory and Hypertension Unit, Institute of Research imas12, Madrid, Spain; 9. CIBER-CV, Hospital Universitario 12 de Octubre, Madrid, Spain; 10. Faculty of Sport Sciences, European University of Madrid, Madrid, Spain; 11. Research and Development, Clinical Data Sciences and Analytics, Bayer PLC, Reading, UK; 12. Integrated Evidence Generation and Business Innovation, Bayer PLC, Reading, UK; 13. Cardiovascular and Renal United States Medical Affairs, Bayer U.S. LLC, Whippany, NJ, USA; 14. Clinical Development, Bayer PLC, Reading, UK; 15. Department of Medicine, University of Chicago Medicine, Chicago, IL, USA
Main Contact Person's Name:
Tram Knecht
Main Contact Person's E-Mail:
tram.knecht@bayer.com
#0059
Empagliflozin Reduces Liver Fat in Diabetic and Nondiabetic Subjects
Author/s:
Siham Abdelgani MD, Ahmed Khattab MD, John Adams MD, Gozde Baskoy MD, Marissa Brown PhD, Geoff Clarke PhD, Olga Larvenenko, MD, PhD, Ralph A DeFronzo MD, Muhammad Abdul-Ghani MD, PhD
Organizations/Affiliations:
UTH San Antonio
Main Contact Person's Name:
Siham Abdelgani
Main Contact Person's E-Mail
Abdelgani@uthscsa.edu
#0060
Pathophysiology of Insulin Resistance: Connecting the Dots
Author(S):
Suresh N. Shinde,MD.
Organization/Affiliation:
Academy of Continuing Medical Education & research, Pune,India; Poona Hospital & Research Centre, Pune, India
Main Contact Person's Name:
Dr Suresh N Shinde
Main Contact Person's E-Mail:
acmepune@yahoo.com
#0061
Prevalence And Clinical Characteristics Of Patients With Transthyretin Amyloidosis In The United States And Japan: Results From The Overtture Study
Author/s:
Jason Wright (Pharm.D.), Christian S. Alvarez (Ph.D.), Lai San Hong (Ph.D.), Krister Järbrink (Ph.D.), Neela Kumar(Ph.D.), Christina Pao (Ph.D.), Eric Wittbrodt (Pharm.D.), Shun Kohsaka (M.D.)
Organizations/Affiliations:
AstraZeneca
Main Contact Person's Name:
Christian S. Alvarez
Main Contact Person's E-Mail:
christian.alvarez@astrazeneca.com
#0063
Sotagliflozin Significantly Reduces CV Death and Heart Failure-related Outcomes in Patients with Type 2 Diabetes, Chronic Kidney Disease, and History of Heart Failure
Author/s:
*MB Hardin, PharmD; *AK Carroll, PhD; *MJ Davies, PhD; *M Girard, MS; *P Banks, MS; **B Pitt, MD; ***PG Steg, MD; ****DL Bhatt, MD, MPH
Organizations/Affiliations:
*Lexicon Pharmaceuticals, The Woodlands, TX; **University of Michigan, Ann Arbor, MI; AP-HP, ***Hôpital Bichat, Paris, France; ****Mount Sinai Heart, New York, NY
Main Contact Person's Name:
Belinda Hardin
Main Contact Person's E-Mail
bhardin@lexpharma.com
#0064
Relationship Between Myeloperoxidase And Metabolic Syndrome At Older Patients
Author/s:
Gianina Ioana Constantin1, Simona Opris1, Catalina Monica Pena1
Organizations/Affiliations:
1“Ana Aslan” National Institute of Gerontology and Geriatrics, Bucharest, Romania
Main Contact Person's Name:
Gianina Ioana Constantin
Main Contact Person's E-Mail:
gianina_constantin@yahoo.com
#0066
Renoprotective Effect Of Celastrol In Diabetic Nephropathy In Rats: Implication Of Mirna-192-5p, Mirna-21-5P, And Autophagy Activation
Author/s:
Samar. M. Al-Tantawy*1, Salma. M. Eraky1, Laila. A. Eissa*1
Organizations/Affiliations:
1 Biochemistry Department, Faculty of Pharmacy, Mansoura University,35516, Egypt.
Main Contact Person's Name:
laila A Eissa
Main Contact Person's E-Mail:
Lailaeissa2002@yahoo.com
#0067
The Relationship Between Hypertension and Thoracic Spine Bone Mineral Density: The Multi-Ethnic Study of Atherosclerosis (MESA)
Author/s:
Ahmed K Ghanem, MD; Venkat S. Manubolu, MD, MPH; April Kinninger, MPH; Robyn L. McClelland, PhD; Jaewon Lim MS; Denise Javier, MD; Khadije.Ahmad, MD; Hossein Hamidi, MD; Marziyeh Bagheri, Mina Deljavanghodrati, MD; MD; Matthew J Budoff MD.
Organizations/Affiliations:
The Lundquist institute at Harbor-UCLA.
Main Contact Person's Name:
Ahmed Ghanem
Main Contact Person's E-Mail:
ahmed.ghanem@lundquist.org
#0068
Patients Admitted With Diabetic Ketoacidosis And A History Of Non-Alcoholic Fatty Liver Disease Have Greater Risk Of Mortality And Worse Clinical Outcomes
Author/s:
Kenan Rahima MD, Trihealth, Mohamad Hijazi MD, Trihealth, Mhd Kutaiba Albuni MD, Trihealth, Amin Eshghabadi MD, Trihealth, Leonid Khoklov MD, Trihealth, Tochukwu Ikpeze MD, Trihealth
Organizations/Affiliations:
Good Samaritan Hospital, Trihealth
Main Contact Person's Name:
Kenan Rahima
Main Contact Person's E-Mail:
mkenan_rahima@trihealth.com
#0069
Patients With Diabetic Ketoacidosis Affected By Protein Calorie Malnutrition Have In-Patient High Mortality And Increased Resource Utilization, Nation Wide Study
Author/s:
MOHAMMAD AMIN ESHGHABADI MD, KENAN RAHIMA MD, MUAYYAD ALZAMARA MD, MOHAMAD HIJAZI MD
Organizations/Affiliations:
GOOD SAMARITAN HOSPITAL, TRIHEALTH
Main Contact Person's Name:
MOHAMMAD AMIN ESHGHABADI
Main Contact Person's E-Mail:
MOHDAMIN_AMIN@YAHOO.COM
#0070
Higher Resource Utilization And Mortality Among Patients With Heart Failure Admited With Diabetic Ketoacidosis And Chronic Kidney Disease
Author/s:
Kenan Rahima MD, Trihealth, Fayaz Khan MD, Trihealth, Mohamad Hijazi MD, Trihealth, Mhd Kutaiba Albuni MD, Trihealth, Amin Eshghabadi MD, Trihealth, Leonid Khoklov MD, Trihealth, Tochukwu Ikpeze MD, Trihealth
Organizations/Affiliations:
Good Samaritan Hospital, Trihealth
Main Contact Person's Name
Fayaz Khan
Main Contact Person's E-Mail
Fayaz_khan@trihealth.com
#0071
FIGARO-BM, a Biomarker Study of FIGARO-DKD, Reveals New Insights Into the Mode-of-Action of Finerenone
Author/s:
Mario Berger, PhD,1; Tram Knecht, PharmD,2; Lydia Christopher, BSc,3; Laura Goea, PhD,1; Peter Kolkhof, PhD,1; Aidan MacNamara, PhD,1; Richard Nkulikiyinka, MD,1; Andrea Scalise, MD,4; Adam Skubala, PhD,1; Sebastian Voss, PhD,5; Katja Rohwedder, MD,6; Joachim H. Ix, MD,7; Faiez Zannad, MD, PhD,8; Peter Rossing, MD, DMSc,9; Hiddo J. L. Heerspink, PhD,10
Organizations/Affiliations:
1. Bayer AG, Pharmaceuticals, R&D, Wuppertal/Berlin, Germany; 2. Bayer US LLC, Cardiovascular and Renal United States Medical Affairs, Whippany, New Jersey, USA; 3. Bayer UK, Cardiology, Reading, UK; 4. Bayer Hispania SL, Pharmaceutical Development, Barcelona, Spain; 5. CHRESTOS Concept GmbH & Co. KG, Essen, Germany; 6. Bayer AG, Pharmaceuticals, Medical Affairs, Berlin, Germany; 7. UCSD, Department of Medicine, San Diego, California, USA; 8. Université de Lorraine, Nancy, France; 9. Steno Diabetes Center Copenhagen, Herlev, and University of Copenhagen, Copenhagen, Denmark; 10. University Medical Center Groningen, Department of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands
Main Contact Person's Name:
Tram Knecht
Main Contact Person's E-Mail:
tram.knecht@bayer.com
#0072
0072 Efficacy and Safety of Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Diuretic Use: A FIDELITY Analysis
Author/s:
Robert J. Mentz, MD,1; Stefan D. Anker, MD,2 Bertram Pitt, MD,3; Peter Rossing, MD DMSc,4,5; Luis M. Ruilope, MD,6-8; Martin Gebel, PhD,9; Peter Kolkhof, PhD,10; Robert Lawatscheck, MD,11; Katja Rohwedder, MD,12; George L. Bakris, MD,13; Asia Quan, PharmD,14; on behalf of the FIDELIO-DKD and FIGARO-DKD Investigators
Organizations/Affiliations:
1. Department of Medicine, Duke University School of Medicine, Durham, NC, USA; 2. Department of Cardiology (CVK) of German Heart Center Charité and Institute of Health Center for Regenerative Therapies (BCRT), German Centre for Cardiovascular Research (DZHK) partner site Berlin, Charité Universitätsmedizin, Berlin, Germany; 3. Department of Medicine, University of Michigan School of Medicine, Ann Arbor, MI, USA; 4. Steno Diabetes Center Copenhagen, Herlev, Denmark; 5. Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark; 6. Cardiorenal Translational Laboratory and Hypertension Unit, Institute of Research imas12, Madrid, Spain; 7. CIBER-CV, Hospital Universitario 12 de Octubre, Madrid, Spain; 8. Faculty of Sport Sciences, European University of Madrid, Madrid, Spain; 9. Statistics & Data Insights, Bayer AG, Wuppertal, Germany; 10. Research & Early Development, Bayer AG, Wuppertal, Germany; 11. Clinical Research, Bayer AG, Berlin, Germany; 12. Medical Affairs, Bayer AG, Berlin, Germany; 13. Department of Medicine, University of Chicago Medicine, Chicago, IL, USA; 14. Cardiorenal Medical Affairs, Bayer US LLC, Whippany, NJ, USA
Main Contact Person's Name:
Asia Quan
Main Contact Person's E-Mail:
asia.quan@bayer.com
#0064
Relationship between myeloperoxidase and metabolic syndrome at older patients
Author(S):
Gianina Ioana Constantin1, Simona Opris1, Catalina Monica Pena1
Organization/Affiliation:
1“Ana Aslan” National Institute of Gerontology and Geriatrics, Bucharest, Romania
Email Contact:
gianina_constantin@yahoo.com
#0073
Pegozafermin, A FGF21 Analog, For The Treatment Of Non-Alcoholic Steatohepatitis (NASH) Patients With F2/F3 Fibrosis
Author/s:
Deepak L Bhatt, MD, MPH; Arun J Sanyal, MD; Stephen A Harrison, MD; Mildred D Gottwald, PharmD; Shibao Feng, PHD; Germaine D Agollah, PHD; Cynthia L Hartsfield, PHD; Hank Mansbach, MD; Maya Margalit, MD; and Rohit Loomba, MD, MHSc
Organizations/Affiliations:
Mount Sinai Heart, Icahn School of Medicine at Mount Sinai Health System, New York (D.L.B.); Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University, Richmond (A.J.S.); Pinnacle Clinical Research, San Antonio, TX (S.A.H.); 89bio, San Francisco (M.D.G., S.F., G.D.A., C.L.H., H.M.); 89bio, Rehovot, Israel (M.M.); and the NAFLD Research Center, Division of Gastroenterology and Hepatology, Department of Medicine, University of California, San Diego, La Jolla (R.L.)
Main Contact Person's Name:
Cindy Hartsfield
Main Contact Person's E-Mail:
cindy.hartsfield@89bio.com
#0074
Pegozafermin Added To Background GLP-1 Therapy Led To Greater Improvement In Non-Invasive Markers Of Liver Fat, Injury And Fibrosis As Well As Glycemic Control In NASH Patients With F2/F3 Fibrosis At 24 Weeks: A Posthoc Analysis From ENLIVEN
Author/s:
Rohit Loomba, M.D., M.H.Sc., Arun J. Sanyal, M.D., Mildred D. Gottwald, Pharm.D., Shibao Feng, Ph.D., Leo Tseng, Ph.D., Cynthia L. Hartsfield, Ph.D., Hank Mansbach, M.D., Maya Margalit, M.D. and Deepak L. Bhatt, M.D., M.P.H.
Organizations/Affiliations:
NAFLD Research Center, Division of Gastroenterology and Hepatology, Department of Medicine, University of California, San Diego, La Jolla (R.L.); Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University, Richmond (A.J.S.); 89bio, San Francisco (M.D.G., S.F., L.T., C.L.H., H.M.); 89bio, Rehovot, Israel (M.M.); and Mount Sinai Heart, Icahn School of Medicine at Mount Sinai Health System, New York (D.L.B.)
Main Contact Person's Name:
Cindy Hartsfield, PHD
Main Contact Person's E-Mail
cindy.hartsfield@89bio.com
#0075
Association Between G308A Polymorphism Of TNF-Α Gene And TNF-Α Levels, Insulin Resistance And Histological Alterations In Patients With NAFLD
Author/s:
Yethindra Vityala1; Mahesh Palagudi2; Sneha Para3; Ravi Babu Kamma4; Pavithra Kotha4; Shravani Divity5, Tugolbai Tagaev6
Organizations/Affiliations:
1AJ Institute of Medical Sciences and Research Centre, Mangalore, Karnataka, India; 2P.E.S. Institute of Medical Sciences and Research, Kuppam, Andhra Pradesh, India; 3Maheshwara Medical College and Hospital, Hyderabad, Telangana, India; 4SVS Medical College, Mahabubnagar, Telangana, India; 5Government Medical College, Mahabubnagar, Telangana, India; 6I.K. Akhunbaev Kyrgyz State Medical Academy, Bishkek, Kyrgyzstan
Main Contact Person's Name
Yethindra Vityala
Main Contact Person's E-Mail:
yethindravityala10@gmail.com
#0076
The Connection Between Diabetic Kidney Disease And Heart Failure In Individuals With Type 2 Diabetes Mellitus
Author/s:
Rebrova Y, PhD Saienko Y, PhD Marushko Y, Ph.D Professor Mankovsky B
Organizations/Affiliations:
Ukrainian Children’s Cardiac Center, Kyiv, Ukraine
Main Contact Person's Name:
Rebrova Yanina
Main Contact Person's E-Mail:
yaninarebr@gmail.com
#0077
Single-dose GLP-1-based Pancreatic Gene Therapy Maintains Weight Loss After Semaglutide Withdrawal in a Murine Model of Obesity
Author(S):
Alice Liou Fitzpatrick, Suya Wang, Emily Cozzi, Randy Seeley, Jay Caplan, Timothy Kieffer, Harith Rajagopalan
Organization/Affiliation:
Fractyl Health, Inc.
Main Contact Person's Name:
Joseph Giaconia
Main Contact Person's E-Mail:
jgiaconia@fractyl.com
#0078
Effect Of SGLT-2 Inhibitor, Dapagliflozin, On Glycemic Variability In Patients With Reduced Left Ventricular Ejection Fraction Without Diabetes.
Author/s:
Ivanna V. Zubovych, Yanina A. Saienko, Yevhen Yu. Marushko, Borys M. Mankovsky
Organizations/Affiliations:
Ukrainian Children’s Cardiac Center, Kyiv, Ukraine
Main Contact Person's Name:
Ivanna Zubovych
Main Contact Person's E-Mail:
ivannavitalivna1@gmail.com
#0079
Weight Loss: A Changing Paradigm in Insulin Resistant and Diabetic Patients
Author/s:
HT Pretorius M.D.,Ph.D., NM Bodnar CNMT, B Murray, BM Brosal, D Menke AA
Organizations/Affiliations:
Blue Ash Nuclear Medicine LLC
Main Contact Person's Name:
Harold Pretorius
Main Contact Person's E-Mail
htpetorius@msn.com
#0080
Association Of EDARV370A With Glycemic Traits In Latinos Residing In The Southwest
Author/s:
Carrie S. Standage-Beier, M.P.H., R.D.N., Yann C. Klimentidis, Ph.D., Luis A. Garcia, B.S., Oscar D. Parra, M.P.H., Lisa Soltani, M.D., Eleanna De Filippis, M.D./Ph.D., Gabriel Q. Shaibi, Ph.D., Douglas J. Spegman, M.D., Lawrence J. Mandarino, Ph.D., Dawn K. Coletta, Ph.D.
Organizations/Affiliations:
Department of Medicine, Division of Endocrinology, University of Arizona, Tucson, Arizona, USA
Main Contact Person's Name:
Dawn K. Coletta, Ph.D.
Main Contact Person's E-Mail:
dcoletta@arizona.edu
#0083
The LS-IM Score And Its Relation To Direct Measurements Of Insulin Resistance
Author/s:
Charles M. Rowland (1), Fahim Abbasi (2), Michael J. McPhaul (1)
Organizations/Affiliations:
(1) Quest Diagnostics Nichols Institute, San Juan Capistrano, CA 92675, (2) Division of Cardiovascular Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, California 94305
Main Contact Person's Name:
Michael J. McPhaul, MD
Main Contact Person's E-Mail:
michael.j.mcphaul@questdiagnostics.com
#0084
The Impact of Processing Methods on Free Fatty Acids Measurements in Type 2 Diabetes
Author(S)
Abigail Epstein, Medical Student¹*, Raquel Poliwoda, RN¹*, Welbeck Sowah, MA¹, Minka Chikolareva, RN, MS, MBA¹, Oana Sandu, MD¹, *First Author, ¹Albert Einstein College of Medicine, Bronx, NY
Organization/Affiliation
¹Albert Einstein College of Medicine
Main Contact Person's Name:
Oana Sandu
Main Contact Person's E-Mail:
oana.sandu@einsteinmed.edu
#0085
NP 0085 Time-Restricted Eating And Its Impact On Weight Loss, Adipose Tissue Distribution, Lean Mass And Blood Pressure In Women With Cardiometabolic Risk Factors
Author/s:
Vanesa Ivana Rayón Gutiérrez1, RD; Diego Emiliano Chávez Fernández1, RD; Jalil López Orozco1, RD, MSc; Eliud Salvador Aguilar Barrera1,2, RD, MSc.
Organizations/Affiliations:
1Posgraduate Department, CICS-UMA, Instituto Politécnico Nacional. Mexico City, Mexico. 2Asociacion Mexicana para el Estudio de la Diabetes y sus Complicaciones, Mexico City, Mexico.
Main Contact Person's Name:
Eliud Salvador Aguilar Barrera
Main Contact Person's E-Mail:
aguilarbarrerae@gmail.com
#0086
Characterization Of Tirzepatide-Treated Patients Achieving Hba1c <5.7% In The SURPASS 1-4 Trials
Author/s:
Julio Rosenstock1, Stefano Del Prato2, Denise Reis Franco3, Luis Vázquez4, Biyue Dai5, Govinda Weerakkody5, Laura Fernández-Landó5, Angel Rodríguez5, Brandon K Bergman5, Xi Chen (Non-author presenter)5
Organizations/Affiliations:
1 Velocity Clinical Research at Medical City, Dallas, TX; 2 Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy; 3 CPCLIN, Clinical Research Center, Sao Paulo, Brazil; 4 Hospital Marqués de Valdecilla, Santander, Spain; 5 Eli Lilly and Company, Indianapolis, IN, USA
Main Contact Person's Name:
Faustina Jayaprakash
Main Contact Person's E-Mail:
Lilly_Encore_Publications@lilly.com
#0087
Tirzepatide Improved Markers of Islet Cell Function (Fasting Glucagon and HOMA2-B) and Insulin Sensitivity (Fasting Insulin and HOMA2-IR) Compared to Semaglutide in People with Type 2 Diabetes
Author/s:
Katelyn Brown1, Laura Fernandez Landó1, Brandon Bergman1, Melissa K. Thomas1, Bing Liu1, Clare Lee1, Amanda M. Giebel (Non-author Presenter)1
Organizations/Affiliations:
1Eli Lilly and Company, Indianapolis, IN, USA
Main Contact Person's Name:
Faustina Jayaprakash
Main Contact Person's E-Mail:
Lilly_Encore_Publications@lilly.com
#0088
BMF-219: A Novel Therapeutic Agent To Reestablish Functional Beta Cells And Provide Long-Term Glycemic Control
Author/s:
Juan P. Frias, MD, Sanchita Mourya, MD, Brian Munneke, PhD, Mini Balakrishnan, PhD, Priyanka Somanath, PhD, Thomas Butler, MS, MBA
Organizations/Affiliations:
Biomea Fusion
Main Contact Person's Name:
Juan P. Frias
Main Contact Person's E-Mail:
jfrias@biomeafusion.com
#0089
Efficacy Of Ayurveda Based Panchakarma Therapy And Diet Treatment To Reduce Down The Dependency Of OHA In Type 2 Diabetes: An Observational Study
Author/s:
1. Dr Sachin Patil- MD Panchakarm-Regional Head 2. Dr Suvarna Pol - MD Panchakarma -Clinic Head 3. Dr Madhumati Sapkar- BAMS -Clinic Head 4.Dr Nilesh Kulthe- MD kay chikitsa -Zonal Medical Head 5.Dr Sai Patil-MD Samhita - Clinic Head
Organizations/Affiliations:
Vaidya Sane Ayurved Laboratories Limited
Main Contact Person's Name:
Dr. Sachin Patil
Main Contact Person's E-Mail:
dr.sachinpatil@madhavbaug.com
#0091
Effectiveness And Safety Of An Adjuvant Phytoformula In The Treatment Of Patients With Type 2 Diabetes Mellitus.y Of Ayurveda Based Panchakarma Therapy And Diet Treatment To Reduce Down The Dependency Of OHA In Type 2 Diabetes: An Observational Study
Author/s:
Nidia Angélica García Espinoza, DACM (1), Hugo Morales Tello, DACM (1), Ricardo Sacchi Córdova, BS (1), Nicasio Morales Sarabia, BS (1), Jair Isaí Ortega Gaxiola, PhD (1), José Alfredo Primelles Gingele, BS (1), María Magdalena Valencia Gutiérrez, MD, MPH (2), Erick Ayala Calvillo, PhD (3), *Cesar Ochoa Martinez, MD, PhD (4).
Organizations/Affiliations:
(1) SAPI de C.V. – División Elevate® (2) Escuela Superior de Medicina, Instituto Politécnico Nacional, CDMX, México, Especialista en Medicina Familiar IMSS/UNAM. (3) Facultad de Farmacia, Universidad Autónoma del Estado de Morelos. Cuernavaca, Morelos, México. (4) Center for Clinical Research, WesternU Medical Center at Western University of Health Sciences, Pomona, CA, USA.
Main Contact Person's Name:
Cesar Ochoa, MD, PhD
Main Contact Person's E-Mail:
drcochoa@hotmail.com
#0093
Effect Of Tirzepatide On The Progression Of Coronary Atherosclerosis Using MDCT: Rationale And Design Of The Tirzepatide Treatment On Coronary Atherosclerosis Progression (T-PLAQUE)
Author/s:
Hossein Hamidi, MD; Marziyeh Bagheri, MD; Denise A Javier, MD; Ahmed Ghanem, MD; April Kinninger, MPH; Hooman Fazlalizade, MD; Mina Deljavanghodrati, MD; Sajad Hamal; Sina Kianoush, MD; Matthew J. Budoff, MD
Organizations/Affiliations:
The Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center
Main Contact Person's Name:
Hossein Hamidi
Main Contact Person's E-Mail:
hossein.hamidi@lundquist.org
#0094
Carbohydrate Restriction-Induced Elevations In LDL-Cholesterol And Atherosclerosis: The KETO Trial
Author/s:
Matthew Budoff1, Venkat S. Manubolu1, April Kinninger, Nicholas G. Norwitz, David Feldman, Thomas R. Wood, Ricardo Cury, Theodore Feldman, Jonathan Fialkow, Khurram Nasir
Organizations/Affiliations:
Lundquist Institute
Main Contact Person's Name:
Matthew Budoff
Main Contact Person's E-Mail:
mbudoff@lundquist.org
#0095
Effect Of Sodium-Glucose Transport Protein 2 Inhibitors On All-Cause Mortality In Patients With Gout: A Multi-Center Cohort Study
Author/s:
Shu-Yen Chan MD, MSc, Kevin Sheng-Kai Ma, DDS, PhD
Organizations/Affiliations:
Department of Internal Medicine, Weiss Memorial Hospital/ Uhicago, Chicago, USA; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA
Main Contact Person's Name:
Shu-Yen Emily Chan
Main Contact Person's E-Mail:
chan0514.eras@gmail.com
#0096
Cardiometabolic Risk Factors in Type 2 Diabetes Persons Evaluated by Continuous Glucose Monitoring
Author/s:
Andreea Morosanu, MD, PHD, Assoc. Prof., Magdalena Morosanu, MD, PHD, Assoc. Prof.
Organizations/Affiliations:
1 Diamed Obesity SRL, Galaţi – Department of Diabetes, Nutrition and Metabolic Diseases, 2 "Dunarea de Jos" University of Galati, Crossborder Faculty
Main Contact Person's Name:
Andreea Morosanu
Main Contact Person's E-Mail
andreeamorosanu17@gmail.com
#0099
Lower Serum Uric Acid Level In Patients With Gout Concurrent Type 2 Diabetes Mellitus Treated With Sodium-Glucose Cotransporter 2 Inhibitors Compared To Dipeptidyl Peptidase-4 Inhibitors: A Population-Based Cohort Study
Author/s:
Shu-Yen Chan MD MSc, Pin-Chia Huang MSc, Kevin Sheng-Kai Ma DDS PhD
Organizations/Affiliations:
Department of Internal Medicine, Weiss Memorial Hospital, Chicago, IL, USA, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA,
Main Contact Person's Name:
Emily Shu-Yen Chan
Main Contact Person's E-Mail
chan0514.eras@gmail.com
#0101
An Assessment Of Demographics And Clinical Outcomes Among Patients With Gestational Diabetes With And Without Diagnosis Of PCOS, Nation-Wide Study
Author/s:
Sindhu Kishore, M.D., Leonid Khokhlov, M.D., Mohammad Hijazi, M.D., Gehna Kishore, M.D., Michael Eerhart, M.D.
Organizations/Affiliations:
Good Samaritan Hospital
Main Contact Person's Name:
Sindhu Kishore
Main Contact Person's E-Mail:
sindhu_kishore@trihealth.com
#0102
Diabetics And Insulin Resistant Patients, Especially Post COVID-19, Have An Increased Biologic Age From Analysis Of Brain FDG PET
Author/s:
HT Pretorius MD,PhD., GM Hubbell MD, B Budke CNMT, NM Bodnar BS,CNMT, B Murray, BM Brosal, D Menke AA.
Organizations/Affiliations:
Blue Ash Nuclear Medicine, LLC
Main Contact Person's Name:
Harold T. Pretorius, M.D., Ph.D.
Main Contact Person's E-Mail:
htpretorius@msn.com
#0103
Pregnants Obesity And Diabetes: A North-African Report
Author/s:
H. Boutrid (MD, PhD), N. Boutrid (MD, PhD), S. Chaat (MD), M. Keghouche (MD), H. Rahmoune (MD), N. Baiben (MDc), A. Baiben (MDc), F. Madaci (MD, PhD)
Organizations/Affiliations:
Faculty o Medicine, University of Setif-1
Main Contact Person's Name
Hakim RAHMOUNE
Main Contact Person's E-Mail
rahmounehakim@gmail.com
#0104
Diabetes Type 1, HLA Genes And Celiac Disease: An Algerian Pediatric Cohort
Author/s:
H. Rahmoune 1.2 (MD), N. Boutrid 1. (MD, PhD), N. Baiben 1 (MDc), A. Baiben 1 (MDc), M. Amrane 1 (MD, PhD)
Organizations/Affiliations:
1: LMCVGN Laboratory, Faculty of Medicine, Sétif-1 University 2: Pediatrics, Setif University Hospital
Main Contact Person's Name:
Hakim RAHMOUNE
Main Contact Person's E-Mail:
rahmounehakim@gmail.com
#0105
Diabetes, Β Cell Apoptosis And The Role Of SIRT2 And Rel/A Nfkb Subunit
Author/s:
Abdemalek Rezgui1 (PhD c), Recha Amel Tachour2(PhD c), Rania Derguine3(PhD c), Anfel Benmesseur 2(PhD c), Fatma Zahra Hab2(PhD c) , Rym Agred1 (PhD), Hakim Rahmoune4 (MD), Nada Boutrid4. (MD, PhD), N. Baiben4 (MD c), A. Baiben4 (MD c), Widad SOBHI1(PhD)
Organizations/Affiliations:
1: Laboratory of Plant Biotechnology and Ethnobotany, Faculty of Nature and Life Sciences, University of Bejaia, 06000, Bejaia, Algeria 2: Research Center of Biotechnology (CRBT), Ali Mendjli, 25000 Constantine, Algeria 3: Laboratory of Applied Biochemistry, Faculty of Nature & Life Sciences, Ferhat Abbas Setif 1 University, Algeria 4: Faculty of Medicine, University of Setif-1, Algeria
Main Contact Person's Name:
Hakim RAHMOUNE
Main Contact Person's E-Mail:
rahmounehakim@mail.com
2022 Accepted Abstracts
Abstracts will be published in the Metabolism Journal
Editor-in-Chief: Christos S. Mantzoros, MD, DSc, PhD h.c. mult.
#0001
Value of Breastfeeding in Pregnant with Gestational Diabetes Mellitus
Abdelghani S.M
#0002
Syringic acid ameliorates experimental diabetic nephropathy in rats through its antiinflammatory, anti-oxidant and anti-fibrotic effects by suppressing Toll like receptor-4 pathway
Omar M. Zabad* 1 , Yara A. Samra1 , Laila A. Eissa* 1
#0004
Non-HDL-cholesterol and atherogenicity in type 2 diabetes mellitus patients
Simona Opriş*, Gianina-Ioana Constantin
#0005
Factors associated with hepatic steatosis in adult Greek subjects with type 2 diabetes mellitus
Angeliki Meritsi, MD1, Emanuel Manesis MD2, Marina Noutsou1 Panagiotis Koussis3, Stamatia Rapti4, Dimitra Latsou5, Ioannis Tsorlalis1, Eustathios Tsitsopoulos4, Hariklia Moshoyianni6, Spilios Manolakopoulos7, Dimitrios Pektasides8, Anastasia Thanopoulou, MD1
#0006
Blood based biomarkers as non-invasive screening tools for hepatic fibrosis in subjects with Type 2 Diabetes Mellitus.
Angeliki Meritsi, MD1, Dimitra Latsou2, Ioannis Tsorlalis1, Marina Noutsou1, Emanuel Manesis MD3, Ilias Gatos4, Ioannis Theotokas MD4, Pavlos Zoumpoulis MD4, Stamatia Rapti5, Eustathios Tsitsopoulos5, Hariklia Moshoyianni6, Spilios Manolakopoulos MD7, Dimitrios Pektasides MD8, Anastasia Thanopoulou, MD1
#0007
Development of Cardiac specific Neurohormonal based diagnostic marker for Diabetes linked cardiac failure
Iram Murtaza, Iram Mushtaq, Ayesha Ishtiaq
#0008
miRNAs and Endothelin: A potential nexus in the roadmap for diabetes linked cardiac complications therapeutic strategy
Ayesha Ishtiaq, Iram Mushtaq, Iram Murtaza
#0009
FTO, PPAR-γ and ABCC8 gene variation and hypertension as determinants of cardiometabolic risk in CVD patients
Kanwal Rehman1,2,, Sania Niaz2, Ayesha Tahir2, Komal Jabeen1,2, Muhammad Sajid Hamid Akash3
#0010
Insulin resistance susceptibility is associated with BPA exposure
Muhammad Sajid Hamid Akash1, Abdul Qader1, Kanwal Rehman2
#0011
Long-term exposure of Bisphenol A impairs metabolism and develop insulin resistance
Kanwal Rehman1, Abdul Qader2, Muhammad Ejaz ul Haq2, Muhammad Sajid Hamid Akash2
#0012
The use of Rozuvastatin (Rozuvastatin Denk) and Metformin combination in women with abdominal obesity
K.Tchaava, N.Gegeshidze ,M.Shavdia, N.Ninashvili, M.Gogiashvili
#0013
Comparison of New-Onset Diabetes Mellitus among Patients with Atrial Fibrillation or Atrial Flutter
WEI SYUN HU
#0014
Role of CHA 2 DS 2-VASc score in predicting new-onset atrial fibrillation in patients with type 2 diabetes mellitus with and without hyperosmolar hyperglycaemic state: real-world data from a nationwide cohort
WEI SYUN HU
#0015
A nationwide cohort study of the role of CHADS 2 score in predicting lower extremity amputation and death among patients with peripheral arterial occlusive disease
WEI SYUN HU
#0016
Diabetes and Cancer. How far off cancer-screening uptake among female diabetic patient?
Noraidatulakma Abdullah1,2, Azmawati Nawi1,3, Mohd Arman Kamaruddin1, Nazihah Jalal1, Rahman Jamal1.
#0017
Demographics of COVID 19 admitted patients and obesity: a retrospective study
Vlachopoulou M., Sarantis N., Chatzis G.
#0018
Sitagliptin on carotid intima-media thickness in type 2 diabetes and hyperuricemia patients: A subgroup analysis of the PROLOGUE study
Yipin Zhao, Zebin Lin, Qingwei Chen
#0019
A review on the role of Phytosterol enriched food in anticancer activity
Anup Ghosal
#0020
Reversing Time: A possibility through chronobiology EFFECT OF TINE RESTRICTED MEAL INTAKE ON ANTHROPOMETRIC AND BIOCHEMICAL PARAMETERS IN TYPE 2 DIABETICS
Dr.Smriti Rastogi1, Dr.Narsingh Verma2
#0021
Telomere length of the gums of patients with diabetes mellitus in non-alcoholic fatty liver disease
Dmitry Emelyanov, Nataliya Emelyanova, Tatyana Petrushanko, Valentina Galchinska, Tatyana Bondar, Olena Otchenashenko1
#0022
Metabolic complications of highly active antiretroviral therapy in adult HIV-infected patients with heart failure: A 7-year prospective cohort study
Kevin Sheng-Kai Ma
#0024
Aldose Reductase inhibition by AT-001 Prevents Diabetic Cardiomyopathy Via Reducing Myocardial Fatty Acid Oxidation Rates
Keshav Gopal1,2, Qutuba G Karwi1, S. Amirhossein Tabatabaei-Dakhili1,2, Cory S. Wagg1, Riccardo Perfetti3, Ravichandran Ramasamy4, John R Ussher1,2, Gary D Lopaschuk1
#0025
Cardio-metabolic factors associated to mortality in patients with COVID-19
Camey Eduardo, M.D., Arauz Guillermo, M.D., Cárcamo Alejandra, M.D, Celis Grecia, M.D.
#0026
Trends in Hyperinsulinemia Among U.S. Adults without Diabetes: A Joinpoint Analysis
James R. Churilla, PhD, MPH, Tammie M. Johnson, DrPH, MPH, Michael R. Richardson, Ph.D., MSH, MS, and Ralph G. Cosentino, MSH
#0027
Leveraging Automated Machine Learning to provide NAFLD screening diagnosis: Proposed machine learning models
Ali Haider Bangash*(1),(2)§, Arshiya Fatima(1)§, Saiqa Zehra(1)§, Ali Haider Shah(1)§, Syed Mohammad Mehmood Abbas(1)§, Syed Muhammad Qasim Shah(1)§, Ayesha Khalid(1)§, Hashir Fahim Khawaja(1)§, Adil Baloch(1)¶, Ali Danish Khan(1)¶, Aliya Ali(1)¶, Aymen Yunus(1)¶, Farhan Faisal(1)¶, Gulfam Jameel(1)¶, Kashaf Mushtaq(1)¶, Maryam Naveed Abbasi(1)¶, Mehwish Nawaz(1)¶, Mishal Bilal(1)¶, Muhammad Ashraf(3)¶, Musa Kamil(1)¶, Noor Ayesha*(1)¶, Rabia Mohsin(1)¶, Sadaf Khalid(1)¶, Saleha Yurf Asghar(1)¶, Syeda Tatheer Zahra(4)
#0028
Is coffee a potential appetite suppressant?
M. Sedanur MACİT, Eda KÖKSAL
#0029
The Association Between Adiponectin and Myocardial Infarction in Patients with Nonalcoholic Fatty Liver Disease
Tulio Loyola Correa, Mariana Sandoval Terra Campos Guelli
#0030
Fat mass paradox and carotid intima-media thickness progression: A longitudinal study from childhood through young adulthood
Andrew O. Agbaje MD, MPH1, Alan R. Barker PhD2, Tomi-Pekka Tuomainen MD, PhD1
#0031
Adolescence arterial stiffness precedes elevated blood pressure in young adulthood: The ALSPAC birth cohort
Andrew O. Agbaje MD, MPH1, Alan R. Barker PhD2, Tomi-Pekka Tuomainen MD, PhD1
#0032
Longitudinal and bi-directional associations of arterial stiffness with general and central fat mass from adolescence through young adulthood: The ALSPAC Study
Andrew O. Agbaje MD, MPH1, Alan R. Barker PhD2, Tomi-Pekka Tuomainen MD, PhD1
#0033
Omega-3 Fatty Acids intervention and DASH Diet Ameliorates Metabolic profiling in Patients with Diabetes Mellitus Type 2
Faisal Ali , Ahmad Al-Junaid, Ali Mohamed Saleh
#0034
BODY WEIGHT CHANGE IN HYPERCOLESTROLEMIC RATS MODEL AFTER INTERVENTION WITH AVOCADO (Persea americana Mill) JUICE
Muhammad Luthfi Adnan1, Raihan Lucky Buana1, Dimas Agus Cholili1, Hilmi Ardian Sudarto1, Amalia Adityas Dyah Safitri1, Tiar Ramadhan1, Miranti Dewi Pramaningtyas1
#0035
Liraglutide in Treatment of Diabetes Mellitus Type 2: Systematic Review and Bibliometric Analysis Over The Last Two Decades
Manar Ahmed Kamal 1 , Raneem Mahmoud Al-Arawi 2
#0036
Vitamin D status and its Association with Atherogenic Index of Plasma in Young Subjects with PCOS
Vipan Talwar
#0037
Effects of bariatric surgery versus pharmacological treatment on oxidative stress in metabolic syndrome
Tomas Augusto Castillo1, Micaela Milagros Rossi1, María de la Paz Scribano Parada1, Franco Signorini1,2, Ismael Fonseca3, María del Carmen Baez1.
#0038
The Effect of Diabetes Mellitus and Revascularization Status on Cardiorespiratory Fitness in Multi-vessel Acute Coronary Syndrome Patients
Hye-Su Yun1, Hee-Jung Lee1, Cheol Hyun Lee1, Yun-Kyeong Cho1, Hyuck-Jun Yoon1, Jin-Wook Chung1, Hyungseop Kim1, Chang-Wook Nam1, Seung-Ho Hur1, Jong-Chan Youn2, and In-Cheol Kim1*
#0042
Polymorphism of apolipoprotein E in children with metabolic diseases of the biliary tract
Belousova OYu, D.Med.Sc., Shutova OV, Pavlenko NV, Solodovnichenko IG, Вabadzhanian OM, Voloshyna LG, Hanzii OB, Abbas Kaafarani, Savytska KV, PhD., Kazaryan LV
#0043
Role of SORT1 gene in patients with Coronary Artery Disease.
Shelly aggarwal, Rajiv Narang, Daman Saluja, Kamna Srivastava